ADVISORY/GeneExpression Systems Presents BioArrays-2003-New York Meeting.

Business Editors/Health/Medical Writers

ADVISORY...for Wednesday-Thursday (Oct. 1-2)

BIOWIRE2K

WALTHAM, Mass.--(BUSINESS WIRE)--Sept. 22, 2003

GeneExpression Systems, Inc., is an emerging biotech company, that specializes in organizing cutting-edge technology seminars and marketing cell and molecular reagents to research community.

UP COMING
SEMINARS:   "BioArrays-2003-New York" meeting on 'Biochips in
            Diagnostics, Industrial Genomics & Proteomics:
            Systemomics(TM) Approaches' to be held at: Holiday Inn
            Midtown, 440 West 57th St. New York City, October 1-2,
            2003.

            "RNAi-2004-Boston" meeting on 'RNA interference: Biology
            to Drugs & Therapeutics' to be held at DoubleTree Guest
            Suites, Waltham, MA, May 2-4, 2004.

DETAILS:    Visit: www.expressgenes.com

BUSINESS
DEALS:      GeneExpression Systems of Waltham, USA has signed an
            exclusive marketing agreement with Synvolux Therapeutics
            B.V. of Groningen, The Netherlands, to distribute
            Saint-Mix, a novel in vivo and in vitro gene delivery
            reagent, which can be used for transfecting DNA, antisense
            and siRNAs. In a separate deal, it also signed agreement
            with Dyomics GmbH, Jena, Germany to market new diode laser
            compatible fluorescent labels that are used in BioArrays
            field. Dr. Krishnarao Appasani, the founder of
            GeneExpression Systems, says, "These marketing deals will
            help us to enter into the microarrays and RNAi markets for
            such reagents a great demand exist."

                BioArrays-2003-New York Meeting Details

FOCUS:      Unique Theme to Combine Diagnostics and Industrial Omics!

FORMAT:     This is a focused meeting designed to educate the
            attendees to understand the applications of Biochips in
            diagnostics through attending scientific sessions,
            technology workshops, panel discussions and networking
            opportunities.

HIGHLIGHTS: Gene and Protein profiling in various diseases; Biomarkers
            discovery; Bioinformatics; Disease diagnosis and
            prognosis; Diagnostic Arrays

WHO IS IN THE
COMMITTEE:  Renowned scientists from academic and industry formed a
            group to bring experts in the field to educate researchers

WHO IS
PRESENTING: World-class scientists from universities such as: Harvard,
            Yale, Cornell, Rockefeller, Michigan, National Cancer
            Institute; Leaders from Pharmaceuticals including: Abbott
            Labs, AstraZeneca, Pfizer, Millennium and Johnson &
            Johnson; and Emerging leaders from biotech companies
            Amersham, Affymetrix, Protometrix, MetriGenix, Schleicher
            & Schuell and Lynx Therapeutics

TARGET
AUDIENCE:   Executives and Scientists of R&D from biotech and
            pharmaceuticals; Graduate students, Post-docs, and
            Professors from Academia; Investors, business development
            people in life sciences

PANEL
DISCUSSION: Includes scientists, executives, patent lawyers,
            technology transfer Managers, venture capitalists,
            analysts, professional science and business journalists

"If you are new to this field, simply, this is a one-stop shopping for your education, experimental tools and meeting authorities in the Biochips field."

For Registration: Visit: www.expressgenes.com